EventsThe 4th International Online Conference on Materials
Published
This submission belongs to the session S2. Nanomaterials, Nanotechnology and Quantum Materials of the event The 4th International Online Conference on Materials
Published date
29 Oct, 2025
Academic Editor
author-avatarXinyu Liu
Citation
Derya Bal Altuntaş, Nanostructure-Based Voltammetric Biosensors: Versatile Point-of-Care Electrochemical Platform Development, in Proceedings of The 4th International Online Conference on Materials, 3 November–6 November 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Nanostructure-Based Voltammetric Biosensors: Versatile Point-of-Care Electrochemical Platform Development

1. Department of Bioengineering, Faculty of Engineering and Architecture, Recep Tayyip Erdogan University, Rize 53100, Turkey, Turkey (Türkiye)
Abstract

This research investigates innovative nanostructure-enhanced voltammetric biosensing platforms developed for rapid medical diagnostics. Our laboratory has engineered electrochemical sensors incorporating advanced nanomaterials, including graphene oxide composites, multi-walled carbon nanotubes, and functionalized gold nanoparticles, demonstrating remarkable improvements in analytical performance metrics compared to traditional diagnostic approaches. The developed point-of-care devices target clinical settings, demanding rapid diagnostic capabilities. These portable systems integrate sophisticated artificial intelligence frameworks, facilitating automated signal processing, pattern classification, and comprehensive clinical decision assistance. Advanced machine learning algorithms enable patient risk assessment, personalized therapeutic guidance, and predictive modeling for disease trajectory analysis. Our nanostructure-modified electrodes exhibit enhanced sensitivity, improved selectivity, and accelerated response kinetics for biomarker quantification. The electrochemical detection platform provides precise, real-time measurements applicable to bedside testing scenarios. Computational intelligence integration supports automated result interpretation and clinical correlation analysis. Key innovations include device miniaturization, cost-efficient manufacturing, and simplified operational protocols. The portable architecture facilitates deployment across varied healthcare environments, from specialized medical centers to resource-limited settings. Automated data processing minimizes user intervention while maximizing diagnostic accuracy. This intelligent biosensing technology represents transformative advancement toward individualized healthcare and targeted diagnostic approaches. Ongoing developments encompass regulatory compliance strategies, manufacturing scale-up initiatives, and seamless integration with digital health platforms for continuous patient surveillance and chronic condition management.

Keywords
electrochemistry
point-of-care diagnostics
clinical translation
nanomaterials
Poster
sciforum-142078.pdf
Phase Transition and Transport Properties in p-Type Mn-doped β-FeSi2 Thermoelectric Materials
Biomedical Applications of Graphene Oxide Nanomaterials: Progress and Prospects